利協清軟膠囊食品
利協清軟膠囊食品 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
- Registration number
- 1149058963
- Chinese name
- 利協清軟膠囊食品
- English name
- NEW E.G.S LISHACHE CAPSULE
- Type
- Imported tablets and capsules
- Published status
- Status not provided in this export; the validity date is shown separately
- Licence holder
- 安利行有限公司
- Registration date
- 2025-08-28
- Published validity end
- 2030-08-28
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- À vérifier
The composition lists additive E171 (titanium dioxide), removed from the list of additives allowed in food, supplements included: since 7 August 2022, a supplement containing it can no longer be placed on the market in the Union.
règlement (UE) 2022/63. Regulation (EU) 2022/63: titanium dioxide (E171) removed from the food additives allowed in the EU, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| SALMON OIL | SALMON OIL | Huile de saumon |
| GINKGO BILOBA L. | GINKGO BILOBA L. | Not identified |
| SHARK LIVER OIL | SHARK LIVER OIL | Not identified |
| COENZYME Q10 | COENZYME Q10 | Ubiquinone |
| GRAPE SEED OIL | GRAPE SEED OIL | Not identified |
| BORAGE SEED OIL | BORAGE SEED OIL | Not identified |
| L-PHENYLALANINE | L-PHENYLALANINE | Not identified |
| DL-ALPHA-TOCOPHERYL ACETATE(VITAMIN E) | DL-ALPHA-TOCOPHERYL ACETATE(VITAMIN E) | Vitamine E |
| GARLIC OIL | GARLIC OIL | Not identified |
| LECITHIN | LECITHIN | Not identified |
| GELATIN | GELATIN | Not identified |
| GLYCEROL | GLYCEROL | Glycérol |
| WATER | WATER | Not identified |
| FAST GREEN FCF | FAST GREEN FCF | Not identified |
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | Not identified |
| SORBIC ACID | SORBIC ACID | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Product name
- 利協清軟膠囊食品
- Active ingredients
- SALMON OIL;;GINKGO BILOBA L.;;SHARK LIVER OIL;;COENZYME Q10;;GRAPE SEED OIL;;BORAGE SEED OIL;;L-PHENYLALANINE;;DL-ALPHA-TOCOPHERYL ACETATE(VITAMIN E);;GARLIC OIL;;LECITHIN;;GELATIN;;GLYCEROL;;WATER;;FAST GREEN FCF;;TITANIUM DIOXIDE;;SORBIC ACID;;
- Valid until
- 1190828
- Registration number
- 1149058963
- Licence holder
- 安利行有限公司
- Registration date
- 1140828
- Published reference
- DHC0B490589633
- Published English name
- NEW E.G.S LISHACHE CAPSULE
Official source
View the official register, number 1149058963
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
Open Government Data License, version 1.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- GINKGO BILOBA L.
Read the warning, when it applies and the studies cited
GINKGO - GINKGO BILOBA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are having a surgery (Gardner and McGuffin 2013).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- COENZYME Q10
Read the warning, when it applies and the studies cited
Coenzyme Q10 (UBIQUINONE-10)
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing more than 100 mg of Coenzyme Q10 per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Migraine prophylaxis/prevention.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.